Evidence map›Paper›PMID 7850068›Full record

ReviewVirchows Archiv : an international journal of pathology1994

Carcinomas of the breast with endocrine differentiation: a review.

H M Maluf, F C Koerner

Abstract readReview
PubMed Publisher
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 92 citations in OpenAlex.

  1. Neuroendocrine neoplasms of the breast: a review of literature.Virchows Archiv : an international journal of pathology · 2024
    Review
  2. Review
  3. Review
  4. Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2018
    Article
  5. Article
  6. Primary Neuroendocrine Carcinoma of Breast.Indian journal of surgical oncology · 2015
    Article
  7. Article
  8. Review
  9. Article
  10. Melatonin anticancer effects: review.International journal of molecular sciences · 2013
    Article
  11. Article
  12. Primary neuroendocrine breast cancer, how much do we know so far?Medical oncology (Northwood, London, England) · 2012
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Primary neuroendocrine tumor of the breast.Medical oncology (Northwood, London, England) · 1997
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

H M MalufDepartment of Pathology, Veterans Administration Medical Center, TN 38104.
F C Koerner
Massachusetts General Hospital · USUnited States Department of Veterans Affairs · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The occurrence of endocrine differentiation in some mammary carcinomas seems well-established, but pathologists continue to debate its significance. Contemporary thinking suggests that endocrine tumours of the breast do not constitute a single clinicopathological entity with a consistent histogenesis but rather that endocrine differentiation represents a pathway of neoplastic development available to a range of breast cancers. This pattern of differentiation occurs in tumours with vastly different morphological appearances, such as: ductal carcinoma in situ, mucinous carcinoma, a variant of lobular carcinoma, and low grade invasive ductal carcinoma. Although such tumours share some characteristics with intestinal endocrine neoplasms, the typical pattern of intestinal carcinoid virtually never occurs in mammary lesions. Conventional microscopy permits the diagnosis in most cases. Specialized techniques (histochemistry, immunohistochemistry, and electron microscopy) can serve as the basis for diagnosis in the absence of the appropriate morphological features. Although the system of nomenclature proposed by the World Health Organization for use with endocrine tumours in other organs can be used for endocrine tumours of the breast, only a minority of lesions will fit the established criteria. Most lesions are classifiable in the conventional categories of mammary carcinomas. No special prognostic significance is attached to these tumours at the present time.

Indexed as

Breast NeoplasmsCarcinomaHumansNeuroendocrine TumorsPrognosisTerminology as Topic

Identifiers

PMID7850068
OpenAlexW2067799960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.